342 related articles for article (PubMed ID: 11923581)
1. Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line.
Prakash O; Tang ZY; Zhou P; Peng X; Kolls J; Shellito JE; Nelson S
Alcohol Clin Exp Res; 2002 Mar; 26(3):295-302. PubMed ID: 11923581
[TBL] [Abstract][Full Text] [Related]
2. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.
Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339
[TBL] [Abstract][Full Text] [Related]
3. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
[TBL] [Abstract][Full Text] [Related]
5. Alteration of thymidine kinase activity in cells treated with an antiviral agent.
Turriziani O; Antonelli G; Verri A; Tozzi V; Ferri F; Riva E; Bambacioni F; Dianzani F
J Biol Regul Homeost Agents; 1995; 9(2):47-51. PubMed ID: 9127632
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
Olivero OA; Tejera AM; Fernandez JJ; Taylor BJ; Das S; Divi RL; Poirier MC
Mutagenesis; 2005 Mar; 20(2):139-46. PubMed ID: 15784690
[TBL] [Abstract][Full Text] [Related]
7. Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudine.
Turriziani O; Scagnolari C; Bambacioni F; Bellomi F; Focher F; Gentile M; Antonelli G
Antivir Ther; 2002 Jun; 7(2):105-11. PubMed ID: 12212922
[TBL] [Abstract][Full Text] [Related]
8. Further study of the mechanism underlying the cellular resistance to AZT.
Turriziani O; Antonelli G; Focher F; Bambacioni F; Dianzani F
Biochem Biophys Res Commun; 1996 Nov; 228(3):797-801. PubMed ID: 8941356
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells.
Hoever G; Groeschel B; Chandra P; Doerr HW; Cinatl J
Int J Mol Med; 2003 Jun; 11(6):743-7. PubMed ID: 12736716
[TBL] [Abstract][Full Text] [Related]
10. Use of herpes simplex virus thymidine kinase to improve the antiviral activity of zidovudine.
Guettari N; Loubière L; Brisson E; Klatzmann D
Virology; 1997 Sep; 235(2):398-405. PubMed ID: 9281520
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the cytotoxicity of 3'-azido-3'-deoxythymidine and methotrexate after transduction of folate receptor cDNA into human cervical carcinoma: identification of a correlation between folate receptor expression and thymidine kinase activity.
Sun XL; Jayaram HN; Gharehbaghi K; Li QJ; Xiao X; Antony AC
Cancer Res; 1999 Feb; 59(4):940-6. PubMed ID: 10029088
[TBL] [Abstract][Full Text] [Related]
13. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.
Avramis VI; Kwock R; Solorzano MM; Gomperts E
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464
[TBL] [Abstract][Full Text] [Related]
14. Ethanol enhances activation-induced caspase-3 dependent cell death in T lymphocytes.
Kelkar S; Dong Q; Xiao Y; Joshi-Barve S; McClain CJ; Barve SS
Alcohol Clin Exp Res; 2002 Mar; 26(3):363-70. PubMed ID: 11923590
[TBL] [Abstract][Full Text] [Related]
15. 3'-azido-3'-deoxythymidine induces deletions in L5178Y mouse lymphoma cells.
Wang J; Chen T; Honma M; Chen L; Moore MM
Environ Mol Mutagen; 2007; 48(3-4):248-57. PubMed ID: 17358034
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mutations in the Tk gene of Tk(+/-) mice treated as neonates with 3'-azido-3'-deoxythymidine (AZT).
Mittelstaedt RA; Von Tungeln LS; Shaddock JG; Dobrovolsky VN; Beland FA; Heflich RH
Mutat Res; 2004 Mar; 547(1-2):63-9. PubMed ID: 15013700
[TBL] [Abstract][Full Text] [Related]
17. Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan.
Tochikura TS; Nakashima H; Kaneko Y; Kobayashi N; Yamamoto N
Jpn J Cancer Res; 1987 Jun; 78(6):583-9. PubMed ID: 3112074
[TBL] [Abstract][Full Text] [Related]
18. Zidovudine (AZT) resistance in H9 cells due to decreased TK expression is associated with hypermethylation of TK gene.
Gröschel B; Höver G; Doerr HW; Cinatl J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):487-92. PubMed ID: 11563064
[TBL] [Abstract][Full Text] [Related]
19. Dominant negative selection of vaccinia virus using a thymidine kinase/thymidylate kinase fusion gene and the prodrug azidothymidine.
Holzer GW; Mayrhofer J; Gritschenberger W; Falkner FG
Virology; 2005 Jul; 337(2):235-41. PubMed ID: 15882885
[TBL] [Abstract][Full Text] [Related]
20. Low-dose, sublingual AZT-monophosphate therapy for HIV+ patients?
Johnson S
Med Hypotheses; 2001 Mar; 56(3):409-10. PubMed ID: 11359372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
